AdvanSix (NYSE:ASIX - Get Free Report) SVP Achilles B. Kintiroglou sold 571 shares of the business's stock in a transaction dated Friday, August 1st. The shares were sold at an average price of $20.18, for a total transaction of $11,522.78. Following the completion of the transaction, the senior vice president directly owned 31,413 shares of the company's stock, valued at $633,914.34. The trade was a 1.79% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.
AdvanSix Stock Performance
ASIX traded down $0.10 during trading on Friday, reaching $18.30. 41,771 shares of the company's stock were exchanged, compared to its average volume of 183,573. AdvanSix has a fifty-two week low of $17.99 and a fifty-two week high of $33.00. The company has a market capitalization of $491.04 million, a P/E ratio of 6.45 and a beta of 1.60. The company has a quick ratio of 0.66, a current ratio of 1.35 and a debt-to-equity ratio of 0.29. The business has a 50 day moving average price of $22.92 and a 200 day moving average price of $24.24.
AdvanSix Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, August 26th. Shareholders of record on Tuesday, August 12th will be issued a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 3.5%. The ex-dividend date of this dividend is Tuesday, August 12th. AdvanSix's payout ratio is currently 22.54%.
Hedge Funds Weigh In On AdvanSix
Several institutional investors have recently modified their holdings of the stock. Victory Capital Management Inc. increased its holdings in AdvanSix by 0.6% during the 1st quarter. Victory Capital Management Inc. now owns 2,407,512 shares of the company's stock worth $54,530,000 after purchasing an additional 15,367 shares in the last quarter. Vanguard Group Inc. lifted its stake in AdvanSix by 1.5% in the 1st quarter. Vanguard Group Inc. now owns 1,981,063 shares of the company's stock valued at $44,871,000 after acquiring an additional 29,963 shares in the last quarter. Dimensional Fund Advisors LP lifted its stake in AdvanSix by 0.8% in the 4th quarter. Dimensional Fund Advisors LP now owns 1,578,908 shares of the company's stock valued at $44,982,000 after acquiring an additional 12,793 shares in the last quarter. American Century Companies Inc. boosted its position in AdvanSix by 11.3% during the 1st quarter. American Century Companies Inc. now owns 823,706 shares of the company's stock worth $18,657,000 after acquiring an additional 83,678 shares during the last quarter. Finally, Wellington Management Group LLP raised its holdings in shares of AdvanSix by 5.7% in the first quarter. Wellington Management Group LLP now owns 712,431 shares of the company's stock valued at $16,137,000 after purchasing an additional 38,546 shares during the last quarter. 86.39% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Several research firms recently issued reports on ASIX. Wall Street Zen downgraded shares of AdvanSix from a "strong-buy" rating to a "buy" rating in a research note on Saturday, August 2nd. Piper Sandler set a $32.00 price target on AdvanSix in a research note on Monday, May 19th.
View Our Latest Stock Report on AdvanSix
AdvanSix Company Profile
(
Get Free Report)
AdvanSix Inc engages in the manufacture and sale of polymer resins in the United States and internationally. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics, and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins, as well as other intermediate chemicals, including phenol, monoisopropylamine, dipropylamine, monoallylamine, alpha-methylstyrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide.
Featured Stories

Before you consider AdvanSix, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AdvanSix wasn't on the list.
While AdvanSix currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.